These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29353736)

  • 1. Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children?
    Bindu PS; Sonam K; Chiplunkar S; Govindaraj P; Nagappa M; Vekhande CC; Aravinda HR; Ponmalar JJ; Mahadevan A; Gayathri N; Bharath MS; Sinha S; Taly AB
    Mult Scler Relat Disord; 2018 Feb; 20():84-92. PubMed ID: 29353736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL): assessment of the involved white matter tracts by MRI.
    Kassem H; Wafaie A; Abdelfattah S; Farid T
    Eur J Radiol; 2014 Jan; 83(1):191-6. PubMed ID: 24558666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation in the first Polish patient.
    Mierzewska H; van der Knaap MS; Scheper GC; Bekiesinska-Figatowska M; Szczepanik E; Jurkiewicz E
    Brain Dev; 2011 Oct; 33(9):713-7. PubMed ID: 21277128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinctive diffusion-weighted imaging features in late-onset genetic leukoencephalopathies.
    De Cocker LJL; Castillo M
    Neuroradiology; 2021 Jan; 63(1):153-156. PubMed ID: 32879996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of epilepsy in patients with mitochondrial disorders: Phenotype genotype and magnetic resonance imaging correlations.
    Bindu PS; Sonam K; Govindaraj P; Govindaraju C; Chiplunkar S; Nagappa M; Kumar R; Vekhande CC; Arvinda HR; Gayathri N; Srinivas Bharath MM; Ponmalar JNJ; Philip M; Vandana VP; Khan NA; Nunia V; Paramasivam A; Sinha S; Thangaraj K; Taly AB
    Clin Neurol Neurosurg; 2018 Jan; 164():182-189. PubMed ID: 29272804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotypic Spectrum and Natural History of Cavitating Leukoencephalopathies in Childhood.
    Zhang J; Liu M; Zhang Z; Zhou L; Kong W; Jiang Y; Wang J; Xiao J; Wu Y
    Pediatr Neurol; 2019 May; 94():38-47. PubMed ID: 30770271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis by whole exome sequencing of atypical infantile onset Alexander disease masquerading as a mitochondrial disorder.
    Nishri D; Edvardson S; Lev D; Leshinsky-Silver E; Ben-Sira L; Henneke M; Lerman-Sagie T; Blumkin L
    Eur J Paediatr Neurol; 2014 Jul; 18(4):495-501. PubMed ID: 24742911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expanding Prominence of Toxic Leukoencephalopathy.
    Filley CM; McConnell BV; Anderson CA
    J Neuropsychiatry Clin Neurosci; 2017; 29(4):308-318. PubMed ID: 28506192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The first pediatric case of leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) from Turkey.
    Çavuşoğlu D; Olgaç-Dündar N; Öztekin Ö; Özdemir TR; Arıcan P; Gençpınar P
    Turk J Pediatr; 2018; 60(2):216-220x. PubMed ID: 30325133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic variants in NUBPL result in failure to assemble the matrix arm of complex I and cause a complex leukoencephalopathy with thalamic involvement.
    Friederich MW; Perez FA; Knight KM; Van Hove RA; Yang SP; Saneto RP; Van Hove JLK
    Mol Genet Metab; 2020 Mar; 129(3):236-242. PubMed ID: 31917109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo detection of connectivity between cortical and white matter lesions in early MS.
    Tillema JM; Weigand SD; Mandrekar J; Shu Y; Lucchinetti CF; Pirko I; Port JD
    Mult Scler; 2017 Jun; 23(7):973-981. PubMed ID: 27698248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiological characteristics in multiple sclerosis patients with large cavitary lesions.
    Renard D; Brochet B; Vukusic S; Edan G; Deburghgraeve V; Goizet C; Dupuy D; Touze E; Deschamps R; Zephyr H; Creange A; Castelnovo G; Boespflug-Tanguy O; Labauge P
    Eur Neurol; 2012; 68(3):156-61. PubMed ID: 22907640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics of cases with leukoencephalopathy with vanishing white matter].
    Wu Y; Jiang YW; Qin J; Xiao JX; Wang JM; Yang YL; Zhang YH; Chang XZ; Lin Q; Wu XR
    Zhonghua Er Ke Za Zhi; 2007 Feb; 45(2):115-20. PubMed ID: 17456339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Leukoencephalopathies in Adults.
    Vanderver A
    Continuum (Minneap Minn); 2016 Jun; 22(3):916-42. PubMed ID: 27261689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation: clinical and genetic characterization and target for therapy.
    van Berge L; Hamilton EM; Linnankivi T; Uziel G; Steenweg ME; Isohanni P; Wolf NI; Krägeloh-Mann I; Brautaset NJ; Andrews PI; de Jong BA; al Ghamdi M; van Wieringen WN; Tannous BA; Hulleman E; Würdinger T; van Berkel CG; Polder E; Abbink TE; Struys EA; Scheper GC; van der Knaap MS;
    Brain; 2014 Apr; 137(Pt 4):1019-29. PubMed ID: 24566671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic analysis of CSF1R-related leukoencephalopathy on magnetic resonance imaging: a case report.
    Huang H; Cao L; Chen H
    BMC Neurol; 2021 Apr; 21(1):156. PubMed ID: 33838643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.
    Ayrignac X; Carra-Dalliere C; Menjot de Champfleur N; Denier C; Aubourg P; Bellesme C; Castelnovo G; Pelletier J; Audoin B; Kaphan E; de Seze J; Collongues N; Blanc F; Chanson JB; Magnin E; Berger E; Vukusic S; Durand-Dubief F; Camdessanche JP; Cohen M; Lebrun-Frenay C; Brassat D; Clanet M; Vermersch P; Zephir H; Outteryck O; Wiertlewski S; Laplaud DA; Ouallet JC; Brochet B; Goizet C; Debouverie M; Pittion S; Edan G; Deburghgraeve V; Le Page E; Verny C; Amati-Bonneau P; Bonneau D; Hannequin D; Guyant-Maréchal L; Derache N; Defer GL; Moreau T; Giroud M; Guennoc AM; Clavelou P; Taithe F; Mathis S; Neau JP; Magy L; Devoize JL; Bataillard M; Masliah-Planchon J; Dorboz I; Tournier-Lasserve E; Levade T; Boespflug Tanguy O; Labauge P
    Brain; 2015 Feb; 138(Pt 2):284-92. PubMed ID: 25527826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction in central nervous system white matter disorders.
    Morató L; Bertini E; Verrigni D; Ardissone A; Ruiz M; Ferrer I; Uziel G; Pujol A
    Glia; 2014 Nov; 62(11):1878-94. PubMed ID: 24865954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the genotype-phenotype spectrum of ISCA2-related multiple mitochondrial dysfunction syndrome-cavitating leukoencephalopathy and prolonged survival.
    Hartman TG; Yosovich K; Michaeli HG; Blumkin L; Ben-Sira L; Lev D; Lerman-Sagie T; Zerem A
    Neurogenetics; 2020 Oct; 21(4):243-249. PubMed ID: 32424628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.